{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:44:18Z","timestamp":1746326658841},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.mehy.2009.01.046","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T11:58:44Z","timestamp":1237463924000},"page":"24-26","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of Behcet\u2019s disease by calcitonin"],"prefix":"10.1016","volume":"73","author":[{"given":"Han","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2009.01.046_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","article-title":"Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club","volume":"17","author":"Devogelaer","year":"2006","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.046_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10067-004-1004-6","volume":"24","author":"Kaskani","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.046_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1533-2500.2002.02042.x","article-title":"Epidural calcitonin: does it provide better postoperative analgesia? An analysis of the haemodynamic, endocrine, and nociceptive responses of salmon calcitonin and opioids in epidural anesthesia for hip arthroplasty surgery","volume":"2","author":"Gabopoulou","year":"2002","journal-title":"Pain Pract"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.046_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10067-006-0228-z","article-title":"The effect of calcitonin on beta-endorphin levels in postmenopausal osteoporotic patients with back pain","volume":"26","author":"Ofluoglu","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.046_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0169-6009(92)90899-O","article-title":"Calcitonin and relief of pain","volume":"16","author":"Pecile","year":"1992","journal-title":"Bone Miner"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2009.01.046_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02001904","article-title":"Calcitonin and its antinociceptive activity: animal and human investigations 1975\u20131992","volume":"41","author":"Braga","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.mehy.2009.01.046_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1679\/aohc.68.143","article-title":"Distribution of actin filaments, non-muscle myosin, M-Ras, and extracellular signal-regulated kinase (ERK) in osteoclasts after calcitonin administration","volume":"68","author":"Nakamura","year":"2005","journal-title":"Arch Histol Cytol"},{"issue":"14","key":"10.1016\/j.mehy.2009.01.046_bib8","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1074\/jbc.M513516200","article-title":"Calpain is required for normal osteoclast function and is down-regulated by calcitonin","volume":"281","author":"Marzia","year":"2006","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.mehy.2009.01.046_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cellbi.2006.12.008","article-title":"Morphological analysis of osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures","volume":"31","author":"Gardner","year":"2007","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.046_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2353\/ajpath.2007.060830","article-title":"Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis","volume":"170","author":"Mancini","year":"2007","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.046_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08820530701745264","article-title":"The genetics of Adamantiades-Behcet\u2019s disease","volume":"23","author":"Durrani","year":"2008","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"10.1016\/j.mehy.2009.01.046_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha treatment in Behcet\u2019s disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mehy.2009.01.046_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight-threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Opthalmol"},{"issue":"1","key":"10.1016\/j.mehy.2009.01.046_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","article-title":"New approaches in the treatment of Adamantiades-Behcet\u2019s disease","volume":"18","author":"Pipitone","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.mehy.2009.01.046_bib15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rhe Dis"},{"issue":"4","key":"10.1016\/j.mehy.2009.01.046_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/rheumatology\/kel382","article-title":"A cost analysis of Beh\u00e7et\u2019s syndrome in Turkey","volume":"46","author":"Sut","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T01:50:42Z","timestamp":1545357042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0306987709001364"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.01.046","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}